Taiwan FDA registration e66e806c2e714c8d68c8512bbeae0c2e

Nofafer Human Mumps Virus Immunoglobulin G Enzyme Immunoassay Kit (Unsterilized)

TW: 諾法鐵人類抗腮腺炎病毒免疫球蛋白G酵素免疫分析套組(未滅菌)
Taiwan flagTaiwan·Risk Class 1·GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH·Registered Mar 16, 2006 – Mar 16, 2026Expired
Registration details
Analysis ID
e66e806c2e714c8d68c8512bbeae0c2e
Customs Code
DHA04400297900
Company information
Manufacturer Country
Germany
Authorized Representative
EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
Intended Use
Qualitative detection of anti-mumps virus immunoglobulin G antibodies in human serum.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.3380 腮腺炎病毒血清試劑
Import Information
Input;; QMS/QSD
Dates and status
Registration Date
Mar 16, 2006
Expiry Date
Mar 16, 2026
About this record

Access comprehensive regulatory information for Nofafer Human Mumps Virus Immunoglobulin G Enzyme Immunoassay Kit (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number e66e806c2e714c8d68c8512bbeae0c2e and manufactured by GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices